- Home
- XOMA vs OLMA Comparison
XOMA vs OLMA Comparison
Compare XOMA & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMA
- OLMA
- Stock Information
- Founded
- XOMA 1981
- OLMA 2006
- Country
- XOMA United States
- OLMA United States
- Employees
- XOMA N/A
- OLMA N/A
- Industry
- XOMA Biotechnology: Pharmaceutical Preparations
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- XOMA Health Care
- OLMA Health Care
- Exchange
- XOMA Nasdaq
- OLMA Nasdaq
- Market Cap
- XOMA 250.1M
- OLMA 289.0M
- IPO Year
- XOMA N/A
- OLMA 2020
- Fundamental
- Price
- XOMA $19.30
- OLMA $3.34
- Analyst Decision
- XOMA Strong Buy
- OLMA Strong Buy
- Analyst Count
- XOMA 2
- OLMA 4
- Target Price
- XOMA $72.00
- OLMA $26.75
- AVG Volume (30 Days)
- XOMA 30.1K
- OLMA 906.8K
- Earning Date
- XOMA 03-17-2025
- OLMA 03-18-2025
- Dividend Yield
- XOMA N/A
- OLMA N/A
- EPS Growth
- XOMA N/A
- OLMA N/A
- EPS
- XOMA N/A
- OLMA N/A
- Revenue
- XOMA $28,487,000.00
- OLMA N/A
- Revenue This Year
- XOMA $29.60
- OLMA N/A
- Revenue Next Year
- XOMA $34.18
- OLMA N/A
- P/E Ratio
- XOMA N/A
- OLMA N/A
- Revenue Growth
- XOMA 498.72
- OLMA N/A
- 52 Week Low
- XOMA $19.12
- OLMA $3.29
- 52 Week High
- XOMA $35.00
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- XOMA 27.79
- OLMA 24.94
- Support Level
- XOMA $20.45
- OLMA $3.93
- Resistance Level
- XOMA $21.45
- OLMA $4.26
- Average True Range (ATR)
- XOMA 0.80
- OLMA 0.32
- MACD
- XOMA 0.05
- OLMA -0.03
- Stochastic Oscillator
- XOMA 6.49
- OLMA 4.08
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.